New Drug for Hepatitis B Approved by the FDA

Medically Reviewed On: November 14, 2006

(HealthCentersOnline) - After a year-long international study, the Food and Drug Administration (FDA) has approved a new drug for the treatment of chronic hepatitis B in adults.

The drug, telbivudine (Tyzeka), is categorized by the FDA as a new molecular entity—a medication that contains an active substance that has never been approved by the FDA for marketing in the United States.

>Click here to read the whole article.